Porsche Automobil Holding SE (PAH3)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 24.72 |
|---|---|
| 52-week range | 24.24 – 41.52 |
| Return, 1 month / 3 months | −5.5% / −10.0% |
| Return, 1 year / 3 years | −24.4% / −33.8% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 25.0% |
| Worst drawdown (1 year) | -37.2% |
| Average daily value traded | 17.72M EUR |
| Dividend yield | 6.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Porsche Automobil Holding SE is a holding company based in Stuttgart, Germany, whose main asset is its investment in Volkswagen, the carmaker. Through that stake it has an interest in a broad range of passenger cars, commercial vehicles and related mobility businesses. The company itself does not build or sell vehicles; it manages its investment and related activities on behalf of its shareholders, and it is controlled by members of the Porsche and Piëch families.
On this site Porsche Automobil Holding SE appears as a stock on the XETRA Stock Exchange (Germany), code PAH3, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Porsche Automobil Holding SE (PAH3) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 24.72 on 23 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 409 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 24.4% and over the last three months it fell 10.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 23 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -16.7% | ||
| From 52-week high | -39.8% | ||
| Momentum | 27 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.0% | ||
| 6-month return | -18.9% | ||
| 12-month return, skipping the last month | -20.0% | ||
| Stability (higher is calmer) | 59 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 25.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.2% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 17.72M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 70 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.1% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −1.1% |
|---|---|
| 1 month | −5.5% |
| 3 months | −10.0% |
| 6 months | −18.9% |
| 1 year | −24.4% |
| 3 years | −33.8% |
| 5 years | −64.4% |
Signals
| 50-day / 200-day average | 26.81 / 29.66 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Jun 2026 | EUR 1.5100 |
| 26 May 2025 | EUR 1.9100 |
| 12 Jun 2024 | EUR 2.5600 |
| 3 Jul 2023 | EUR 2.5600 |
| 16 May 2022 | EUR 2.5600 |
| 26 Jul 2021 | EUR 2.2100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.